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Abstract
Alpha-herpesviruses, including herpes simplex virus and pseudorabies virus (PRV), infect the peripheral nervous system
(PNS) of their hosts. Here, we describe an in vitro method for studying neuron-to-cell spread of infection as well as viral
transport in axons. The method centers on a novel microfluidic chamber system that directs growth of axons into a
fluidically isolated environment. The system uses substantially smaller amounts of virus inoculum and media than previous
chamber systems and yet offers the flexibility of applying multiple virology and cell biology assays including live-cell optical
imaging. Using PRV infection of cultured PNS neurons, we demonstrate that the microfluidic chamber recapitulates all
known facets of neuron-to-cell spread demonstrated in animals and other compartmented cell systems.
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Introduction
An intriguing aspect of the alpha-herpesvirus life cycle in the
natural host is the controlled spread of virus within the peripheral
nervous system (PNS), with rare invasions of the central nervous
system. After establishing a primary infection at peripheral
epithelial tissues, alpha-herpesviruses, such as herpes simplex virus
and pseudorabies virus (PRV), invade the termini of sensory and
motor neurons that innervate the infected site. Following transport
to the cell body through axons (retrograde transport), the viral
genome usually remains latent in the nucleus. Months or years
later, the latent infection can be reactivated, producing newly
assembled viral particles. The viral particles then travel back to the
periphery (anterograde transport), where re-infection of the
epithelia produces infectious virus that can spread to naive hosts
[1]. This long-distance movement of viral particles to and from the
cell body engages microtubule-based fast axonal transport
machinery [2–5].
The transport and targeting mechanisms behind the directional
spread of infection between non-neuronal epithelial cells and
neurons are poorly understood. This is in part due to the lack of
facile in vitro systems that can model the complex biology of inter-
cellular viral transmission. Earlier studies used compartmentalized
Campenot chambers to study alpha-herpesvirus spread [6–15].
These chambers use a Teflon divider sealed to the surface of a
tissue culture dish via a silicone grease layer. Neuronal cell bodies
plated in one compartment extended axons to another compart-
ment by penetrating the silicone grease. More recently, a chamber
system that utilizes a Teflon ring placed on top of axons has also
been developed [16]. These chambers can be challenging to
assemble because slight mechanical disturbances or displacement
of the grease seal can easily cause leakage or severing of neurites.
Moreover, some chamber assemblies were not compatible with
sophisticated microscopy techniques including live-cell imaging.
Microfluidic systems have been increasingly used by cell
biologists to precisely control and manipulate cellular microenvi-
ronments [17–19]. Microfluidic devices fabricated with poly(-
dimethylsiloxane) (PDMS), a transparent and biocompatible
polymer [20,21], have been used for studies of cell migration
[22–26], stem cells [27], and neurons [28,29]. Here, we describe
the use of a microfluidic chamber for culturing PNS neurons that
enables us to analyze neuron-to-cell spread of alpha-herpesviruses
by live-cell imaging as well as standard virology and cell biology
methods.
The microfluidic device consists of a small PDMS piece with
compartments connected by embedded microgrooves [30]. The
whole device is placed against a glass coverslip and holds about
600 ml of media. Neuron cell bodies are cultured in the somal
compartment, while axons extend through 10 mm wide micro-
grooves into the axonal compartment, where detector cells can be
grown (Fig. 1A). A hydrostatic pressure difference between
chambers is sufficient to isolate virions to either the somal or
axonal compartment. Using the microfluidic chamber to study
neuron-to-cell spread and axonal transport of PRV, we established
several key parameters. First, plating non-neuronal epithelial cells
in the axonal compartment enables neuron-to-cell spread of
infection that is dependent on intact axons. Second, the attenuated
vaccine strain PRV Bartha is defective in neuron-to-cell spread.
Third, neuron-to-cell spread requires gB, a viral glycoprotein that
mediates membrane fusion. However, it does not require gD, a
glycoprotein necessary for infection by extracellular virions.
Fourth, neuron-to-cell spread requires Us9, a viral membrane
protein necessary for axonal sorting of viral structural proteins.
Fifth, PRV Bartha has a slight defect in retrograde spread to cell
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image viral protein dynamics in live infected neurons. By imaging
fluorescently tagged virion components, we find that fluorescent
capsid structures associate with the outer tegument during
anterograde transport in axons. In contrast, capsids lacking outer
tegument traveled in the retrograde direction. Finally, we show
that the velocity distribution of light particles lacking capsids is
identical to that of capsids during anterograde transport. Hence,
the microfluidic chamber recapitulates faithfully what has
previously been observed in animal models and in vitro systems.
Methods
Cell and virus strains
The swine kidney epithelial cells (PK15) were cultured in
Dulbecco’s modified Eagle medium supplemented with 10% of
fetal bovine serum and 1% penicillin/streptomycin. All PRV
strains were propagated in PK15 cells. PRV strains used include:
PRV Becker, a virulent isolate [31]; PRV Bartha, an attenuated
vaccine strain [32]; PRV151, PRV Becker expressing green
fluorescent protein (GFP) [33]; PRV152, PRV Bartha expressing
GFP [34]; PRV180, expressing monomeric red fluorescent protein
(mRFP) fused to the capsid protein VP26 [35]; and PRV181,
expressing both GFP-VP22 and mRFP-VP26 fusion proteins [35].
PRV mutants in the PRV Becker background are PRV 160 (Us9
null) [36]; PRV GS442 (gD null mutant with gD replaced by the
GFP open reading frame; provided by G. Smith, Northwestern
University), which was grown on a gD complementing cell line
[37]; and PRV HF22A (gB null mutant), which was grown on a gB
complementing cell line (LP64e3).
Neuronal cultures
Protocols for dissecting and culturing neurons are found in
Ch’ng et al. [38]. Briefly, sympathetic neurons from the superior
cervical ganglia (SCG) were dissected from E15.5 to E16.5
pregnant Sprague-Dawley rats (Hilltop Labs Inc., Pennsylvania)
and incubated in 250 mg/ml of trypsin (Worthington Biochemi-
cals) for 10 min. 1 mg/ml trypsin inhibitor (Sigma Aldrich) was
applied to neutralize the trypsin for 5 min, after which it was
removed and replaced with neuron culture medium. Prior to
Figure 1. The microfluidic chamber system. (A) The chamber consists of a poly(dimethylsiloxane) (PDMS) mold containing mirror image
compartments connected by microgrooves (450 mm in length, 10 mm in width). The PDMS adheres to a coated glass coverslip. Rat superior cervical
ganglia (SCG) neurons are plated in the somal compartment and axon growth is guided into the axonal compartment through the microgrooves. (B)
SCG neurons cultured in the chamber are polarized and mature after 9 d. Confocal microscopy images show neurons in the chamber fixed and
stained for phosphorylated (P) neurofilament H, a somatodendritic marker, and nonphosphoylated (NonP) neurofilament H, an axon-specific marker.
Bar: 150 mm.
doi:10.1371/journal.pone.0002382.g001
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pipette. The neurons were plated in the somal compartment of the
microfluidic chamber placed on a glass coverslip that was
previously coated with 500 mg/ml of poly-dl-ornithine (Sigma
Aldrich) diluted in borate buffer and 10 mg/ml of natural mouse
laminin (Invitrogen). The neuron culture medium consists of
Dulbecco’s modified Eagle medium (Invitrogen) and Ham’s F12
(Invitrogen) in a 1:1 ratio. The serum-free medium was
supplemented with 10 mg/ml of bovine serum albumin (Sigma
Aldrich), 4.6 mg/ml glucose (J. T. Baker), 100 mg/ml of
holotransferrin (Sigma Aldrich), 16 mg/ml of putrescine (Sigma
Aldrich), 10 mg/ml of insulin (Sigma Aldrich), 2 mM of l-
glutamine (Invitrogen); 50 mg/ml or units of penicillin and
streptomycin (Invitrogen), 30 nM of selenium (Sigma Aldrich);
20 nM of progesterone (Sigma Aldrich) and 100 ng/ml of nerve
growth factor 2.5S (Invitrogen). The neuronal cultures are treated
with 1 mM of cytosine b-d-arabinofuranoside (Sigma-Aldrich) to
eliminate any non-neuronal cells two days after plating. The
neuron culture medium was replaced every three days and
cultures were kept in a humidified, CO2 regulated 37uC incubator.
All experimental protocols related to animal use have been
approved by The Institutional Animal Care and Use Committee
of the Princeton University Research Board under protocol
number 1543 in accordance with the regulations of the American
Association for Accreditation of Laboratory Animal Care and
those in the Animal Welfare Act (Public Law 99–198).
Antibodies and fluorescent dyes
The primary antibodies used in this study include mouse
monoclonal antiserum against the PRV major capsid protein VP5
(made by Alex Flood at the Princeton Monoclonal Antibody
Facility [used at 1:100]), rabbit antiserum against phosphorylated
neurofilament H (SMI-31; Abcam [used at 1:400]), and nonpho-
sphorylated neurofilament H (SMI-32; Abcam [used at 1:400]). All
secondary Alexa fluorophores and the Hoechst nuclear dye were
purchased from Molecular Probes.
Microfluidic chamber system
The microfluidic chambers were fabricated as described in [30]
and protocols for assembling the chambers were modified from
previous reports [9,30]. Briefly, glass coverslips were coated with
500 mg/ml of poly-dl-ornithine (Sigma). The chamber was then
placed on the coated glass coverslips until it sealed to the glass
around the chamber. The compartments were loaded with 10 mg/
ml of natural mouse laminin (Invitrogen), incubated overnight and
then washed and dried briefly. Neuronal medium was added to
both compartments 24 h prior to plating the neurons. Each
compartment holds about 300 ml of medium. After the SCG
neurons were dissected and dissociated, approximately one half of
a single ganglion (about 5,000 to 6,000 cell bodies) was plated into
the two wells of one compartment, which we call the somal
compartment (Fig. 1A). Neuron cultures were maintained as
described above. All chambers have a microgroove length of
450 mm and a width of 10 mm.
Assaying for neuron-to-cell spread of infection
Neurons were cultured for two weeks in the microfluidic
chamber before manipulation. Two weeks postplating, after axons
have extended across the microgrooves, PK15 cells were plated in
the axonal compartment in neuronal medium supplemented with
1% fetal bovine serum. The cells were left to attach and contact
the axons for at least 24 h. 330 ml of neuron medium was placed in
the axonal compartment, after which 270 ml of viral inoculum was
added to the somal compartment. This hydrostatic pressure
difference completely prevented diffusion of infectious virions
through the microgrooves. The neuronal cell bodies in the somal
compartment were infected with sufficient virus to infect essentially
all cells (around 10
6 pfu diluted in neuronal medium). Direct
calculations show that the multiplicity of infection (MOI) is around
100. After 1 hour, the viral inoculum was removed and replaced
with 270 ml of neuron medium, with the volume difference
between the two compartments maintained. The chambers were
incubated in a humidified 37uC incubator until the appropriate
time prior to imaging or titer determination. To determine the
titer, PK15 cells in the axonal compartment were gently scraped
from the dish with a pipette tip. The cells and medium were
pooled and titered on PK15 cells.
Detecting axon-mediated infection of neuronal cell
bodies
Two weeks postplating, 330 ml of neuron medium was placed in
the somal compartment. About 10
6 pfu of virus in 270 ml neuron
medium was subsequently added to axonal compartment and
incubated for 1 hour to allow virus entry. The viral inoculum was
then removed and replaced with 270 ml of neuron medium, with
the volume difference between the two compartments maintained.
The chambers were incubated in a humidified 37uC incubator
until the appropriate time after infection. For titer determination,
neurons and medium were harvested from the somal compart-
ment and titered on PK15 cells.
Indirect immunofluorescence assays
Attheappropriatetime afterinfectionofthe somalcompartment,
the somal and axonal compartments were washed once with
phosphate-buffered saline (PBS) and fixed with 4% paraformalde-
hydefor 10 min. After removal of the fixative, the cells werewashed
two more times with PBS. Cells were then incubated with PBS
containing 3% bovine serum albumin (BSA) and 0.5% triton for
10 min, and PBS containing 3% BSA for 30 min before the
additionofprimaryantibodiesfor1 hour.After1 hour,theprimary
antibodieswereremovedand the samplewaswashedtwo timeswith
PBS containing 3% BSA and 0.5% saponin. Next, secondary
antibodies were applied for 1 hour. All antibodies were diluted in
PBS containing 3% BSA and 0.5% saponin. After 1 hour, the
secondaryantibodieswereremoved and thesamplewas washedtwo
times with PBS containing 3% BSA and 0.5% saponin. After
washing once with PBS, and once with dH2O, Aqua poly/mount
(Polysciences) was added to the somal and axonal compartments.
The Aqua poly/mount (Polysciences) was air dried for 24 h prior to
imaging. Wide-field epifluorescence microscopy was performed
using a Nikon Eclipse TE 2000-U microscope equipped with a
Cooke SensiCam High Performance camera. Images wereacquired
using IP lab software (Scanalytics Inc.).
Confocal microscopy and live imaging
Fixed samples were imaged with a Perkin-Elmer (Wellesley,
California, United States) RS3 spinning disk confocal system side-
mounted on a TE2000-S Nikon Eclipse microscope (Tokyo,
Japan) with an Argon/Krypton laser producing excitation lines of
488, 568, and 647 nms. Live imaging was performed using a Leica
SP5 with an HCX Plan Apochromat 63X 1.3NA glycerin
objective. 20 mM HEPES was added to the medium prior to
imaging. The chamber was warmed to 37uC employing a DH40i
Micro-incubation system (Warner Instrument Corp.) run at
constant voltage. Laser lines at 488 and 561 nm were used for
simultaneous GFP and RFP excitation, with emissions from 495 to
553 nm and 587 to 700 nm collected for GFP and RFP
Herpesvirus Spread In Vitro
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detector pinhole and scanning at a speed of 1,000 Hz in a
bidirectional mode. A 3-by-3 kernel median filter was applied to
the data post-acquisition. For tracking of PRV181 particles, over
80 recordings were acquired from three independent experiments
at 11–14 hpi, with each recording typically lasting 2 min and
having a field of view of 50 mm. Average velocities were calculated
from periods of uninterrupted motion in a given direction. All
figures were assembled in Adobe Photoshop 7.0.1.
Results
The Microfluidic Culture System
The microfluidic chamber consists of a molded elastomeric
polymer placed on a glass coverslip (Fig. 1A). A physical barrier
with embedded microgrooves connects the somal and axonal
compartments. Microgrooves that connect the compartments
allow the passage of neurites to the axonal compartment, but
not of cell bodies. Neurite growth is very robust, and typically,
neurites extend into the axonal compartment within 5 days in
culture. After 9 days in culture, cell bodies in the chamber are
readily labeled with the somatodendritic marker nonphosphory-
lated neurofilament H while neurites are labeled with the axonal
marker phosphorylated neurofilament H (Fig. 1B). Only axons
were detected in the axonal compartment.
To demonstrate that virus can be restricted to one compartment
of the chamber, we cultured PK15 cells in both the somal and
axonal compartments of 10 separate chambers. After allowing the
cells to settle and attach for 24 h, we established a volume
difference of 30 ml between the two compartments, with the somal
compartment containing the lesser volume. The hydrostatic
pressure difference counteracts diffusion [39,40]. PK15 cells in
the somal compartment were then infected with GS443, a PRV
strain that expresses the fusion protein GFP-VP26 (green
fluorescent protein fused to the PRV capsid protein VP26). Cells
in both compartments were imaged at 24 and 48 h postinfection.
Infected cells were detected by green fluorescence emitted from
GFP-VP26. In all 10 chambers, only PK15 cells in the somal
compartment were infected (data not shown). None of the PK15
cells in the axonal compartment were infected as demonstrated by
the lack of green fluorescent signal.
Spread of infection from neuron cell bodies to detector
cells in the axonal compartment requires intact axons
We used the chamber to study spread of infection from neurons
to detector cells. After neurons have matured for 2 weeks and
axons have extended to the axonal compartment, we plated PK15
cells in the axonal compartment (n=6 chambers). At 24 h
postplating, complete monolayers formed in the axonal compart-
ment. Neurons in the somal compartment were infected at a high
MOI with PRV 151, a strain that expresses diffusible GFP. For
half the samples, we severed the axons in the axonal compartment
by vacuum aspiration 1 hour postinfection upon removal of viral
inoculum [30]. Due to the high fluidic resistance of the
microgrooves, the cell bodies in the somal compartment remained
undisturbed. We left the remaining samples untreated. After 24 h
postinfection, we detected transmission of infection by GFP
expression. Severing of axons from their cell bodies blocked
neuron-to-cell spread of infection, indicating that transmission of
infection requires the presence of intact axons (Fig. 2). These
results also suggest that spread of infection to the axonal
compartment does not occur through leakage of extracellular
virus particles from the somal compartment.
PRV Bartha is defective in neuron-to-cell spread of
infection
The attenuated vaccine strain PRV Bartha is defective in
anterograde spread from presynaptic to postsynaptic neurons in
many animal models and culture systems [1,16,41]. This defect is
primarily due to a small deletion that results in partial or complete
removal of the gE, gI, and Us9 coding sequences [32,42–44].
However, PRV Bartha can spread in the retrograde direction and
is widely used to trace neuronal circuits [45]. We tested whether
PRV Bartha exhibits the same defect in neuron-to-cell spread of
infection (anterograde spread) in our in vitro chamber as observed
in vivo. We infected cell bodies in the somal compartment with
PRV Becker or PRV Bartha, in parallel. After 20 h, neurons and
cells in the chamber were fixed and stained with antibody against
the major capsid protein VP5 and Hoechst stain to detect nuclei.
We measured the degree of spread by calculating the number of
VP5-positive cells in the axonal compartment from the area of
infected monolayer (n=3 chambers) (Fig. 3A). As expected, PRV
Figure 2. Neuron-to-cell spread of PRV requires intact axons. PK15 cells were plated in the axonal compartment. Neurons in the somal
compartment were then infected at a high MOI with PRV 151, a strain that expresses GFP. At 1 h postinfection, all axons in the axonal compartment
were either severed or left untreated as a control. Cells were fixed at 24 h postinfection and imaged using wide-field epifluorescence microscopy.
Bars: 50 mm.
doi:10.1371/journal.pone.0002382.g002
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the axonal compartment. In contrast, PRV Bartha exhibited a
complete defect in neuron-to-cell spread as no infected cells were
detected in the axonal compartment (Fig. 3B).
In addition, we determined the yield of infectious particles as a
sensitive measure of the degree of infection. PK15 cells in the
axonal compartment were harvested at 20 h postinfection and
titered. We detected plaques only for PRV Becker-infected
chambers and not for PRV Bartha-infected chambers (Fig. 3C).
Hence, our results recapitulate the anterograde spread defect of
PRV Bartha observed in animal models.
Neuron-to-cell spread of infection requires gB and Us9
but not gD
We then tested for viral envelope proteins that were necessary
for mediating neuron-to-cell spread. First, we determined whether
neuron-to-cell spread of infection occurs via a neuron-cell
interaction or by infectious free virions. The viral glycoprotein
gD is required for entry and fusion of extracellular virus to cells,
but is dispensable for direct cell-to-cell spread in vitro and in vivo
[16,41,46–49]. We infected cell bodies in the somal compartment
with PRV GS442, a gD null mutant that expresses GFP (n=3
chambers). We produced infectious PRV GS442 by growing virus
stocks on a gD-expressing cell line. Complemented viruses can
infect once, but the resulting progeny lack gD, and hence these gD
null particles cannot infect extracellularly. Using anti-VP5 and
Hoescht staining, we could readily detect infected cells in the
axonal compartment (Fig. 3A). We scored the number of infected
cells in the chamber infected with the gD mutant by determining
the total area of infected monolayer. We found that the gD null
infection produced a 4-fold decrease in the number of infected
cells compared to a PRV Becker infection (Fig. 3B). This is not
Figure 3. Assaying for viral proteins required for neuron-to-cell spread of infection. Neurons in the somal compartment were infected at
high MOI with PRV Becker, PRV Bartha, GS442 (a complemented gD-null virus that expresses GFP), HF22A (a complemented gB-null virus), or PRV 160
(Us9-null). Three chambers were used for each PRV strain. (A) Epifluorescent images of PK15 cells in the axonal compartment fixed and stained with
antibodies against the VP5 capsid protein and the Hoechst nuclear dye at 20 h postinfection. Neurons in the somal compartment are not shown. (B)
Quantitation of infected cells in the axonal compartment. The number of cells positive for VP5 staining was determined for each chamber by
calculating the total area of infected monolayer. (C) Quantitation of infectious particles in the axonal compartment. Medium and cells in the axonal
compartment were harvested at 20 h postinfection, and the titer was determined on PK15 cells. Bar: 25 mm.
doi:10.1371/journal.pone.0002382.g003
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infected PK15 cells could spread extensively to non-neighboring
cells in the compartment while progeny of PRV GS442 could only
spread between neighboring cells. We then harvested cells in the
axonal compartment from the gD null infection and determined
the titer. We did not detect any plaques (Fig. 3C), indicating that
there were no gD-positive revertants in our gD mutant stocks. We
conclude that neuron-to-cell spread does not require gD.
The essential viral glycoprotein gB is required for spread of
infection via cell-to-cell spread as well as by extracellular particles
in vitro and in vivo [16,48,49]. We confirmed that gB null mutants
are unable to spread from neurons to cells in our chamber. We
infected cell bodies in the somal compartment with a comple-
mented PRV gB null virus (PRV HF22A) and scored for infected
cells in the axonal compartment using anti-VP5 and Hoescht
staining (n=3 chambers). Like a complemented gD null mutant, a
complemented gB null mutant can only infect once as its progeny
do not contain gB and are noninfectious. We did not detect any
cells in the axonal compartment that stained positive for VP5
(Fig. 3A and B). Furthermore, cells in the axonal compartment
failed to produce any plaques (Fig. 3C). These assays confirm that
gB is necessary for neuron-to-cell spread.
Finally, we show that the viral membrane protein Us9 is
required for neuron-to-cell spread. Us9 is necessary for targeting
viral structural proteins to the axon [50,51]. Us9 null mutants are
defective in anterograde spread of infection in the rat visual system
and in cultured neurons [41,50,52]. Upon infecting neuronal cell
bodies with PRV 160, a Us9 null mutant, we failed to detect VP5
staining in cells of the axonal compartment (n=3 chambers)
(Fig. 3A and B). Our plaque assay confirmed that there were no
infectious particles in the axonal compartment at 20 h postinfec-
tion (Fig. 3C).
Axon-mediated infection can occur in the retrograde
direction
Our previous experiments recapitulated viral spread in the
anterograde direction. We next used the chamber to study axon-
mediated infection of cell bodies. We added 10
6 pfu of PRV
Becker (PRV151) or PRV Bartha (PRV152) to the axonal
compartment without plating any detector cells (n=3 chambers).
PRV151 and PRV152 are each recombinant strains expressing
freely diffusible GFP. At 24 h postinfection, we identified infected
cell bodies by fluorescence emission. Both PRV Becker and PRV
Bartha infected cell bodies in the somal compartment, suggesting
that virus entered and traveled through axons in the axonal
compartment to infect cell bodies (Fig. 4A). However PRV Bartha
consistently yielded lower titers in the somal compartment than
PRV Becker (Fig. 4B). This result is consistent with observations
that PRV Bartha spreads slower than PRV Becker in animal
models and in vitro [41,53,54].
Live imaging of capsid and tegument transport
To demonstrate the value of the microfluidic chamber to study
the transport of virion components during viral egress inside the
chamber, we used PRV181, a recombinant virus expressing two
fluorescent proteins: GFP fused with the outer tegument protein
VP22 and mRFP fused to capsid protein VP26 [35]. To ensure
that the fluorescent fusion proteins do not interfere with axonal
transport, we assayed for neuron-to-cell spread of PRV181 and
compared it to that of PRV Becker (n=3 chambers). After
infecting cell bodies in the somal compartment for 24 h, we
harvested and titered cells and medium from the somal and axonal
compartments. Since PRV181 has no replication defect in PK15
cells [35], lower titers would indicate a kinetic defect in spread
from neurons to PK15 cells. We found that PRV Becker and
PRV181 produced comparable titers in both somal and axonal
compartments (t test; alpha=0.05) (Table 1). Hence, we conclude
that PRV181 has no obvious defect in anterograde transport and
proceeded to use the virus for live-cell imaging.
We infected neurons in the somal compartment with PRV181
and imaged progeny viral particles within axons inside the
microgrooves at 11 to 14 hpi, the peak time for capsid transport
Figure 4. PRV Bartha has a slight defect in retrograde spread of
infection to cell bodies. A viral inoculum of PRV151 (a Becker
recombinant expressing GFP) or PRV152 (a Bartha recombinant
expressing GFP) was incubated in the axonal compartment for 1 h
before being replaced with neuronal medium. Three chambers were
used for each PRV strain. (A) Epifluorescent and Hoechst images of cell
bodies in the somal compartment fixed at 20 h postinfection. (B)
Quantitation of infectious particles in the somal compartment. Medium
and cells in the somal compartment were harvested at 20 h
postinfection and titered on PK15 cells. Bar: 50 mm.
doi:10.1371/journal.pone.0002382.g004
Table 1. Titers of PRV Becker and PRV181 in the axonal
compartment upon neuron-to-cell spread of infection.
Somal Compartment Axonal Compartment




6 pfu) 15.364.1 8.767.2 10.368.9 6.264.4
1Average6standard error of the mean.
doi:10.1371/journal.pone.0002382.t001
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axonal compartment. The microgrooves define transport direc-
tion, allowing us to clearly distinguish anterograde from retrograde
motion. We observed three classes of puncta: red, green and
yellow (Fig. 5 and 6; Supporting Information Movie S1 and S2).
The green puncta most likely are light particles containing GFP-
VP22 without capsid, the yellow puncta are heavy particles with
both GFP-VP22 and mRFP-VP26, and the red puncta are capsids
without outer tegument, although small quantities of green
fluorescence may be below our detection limit. Both heavy and
light particles displayed heterogeneity of GFP fluorescence (Fig. 6;
Supporting Information Movie S2), as has been observed for
extracellular virions [35]. mRFP puncta (capsid structures)
traveled predominantly in the anterograde direction, although
processive retrograde transport also occurred at a lower frequency,
as described previously [4]. We observed that almost all mRFP
puncta traveling in the anterograde direction were associated with
GFP-VP22 signal: 238 out of 242 mRFP puncta (98.3%) emitted
GFP fluorescence (Fig. 7). In addition, we observed that GFP-
VP22 puncta frequently traveled in the anterograde direction in
the absence of any detectable mRFP signal (Fig. 7). In contrast,
mRFP puncta moving in the retrograde direction were generally
not coupled with green fluorescence (122 out of 125 total) (Fig. 5
and 7; Supporting Information Movie S1). GFP-VP22 puncta
almost never traveled in the retrograde direction (3 out of 297
total). Hence, processive retrograde transport of capsid structures
occurred in the absence of VP22 (outer tegument) during viral
egress in axons.
To compare the transport dynamics of light and heavy particles,
we tracked individual VP26 (heavy) and VP22 (light) fluorescent
puncta as they traveled inside the microgrooves of the chamber.
The velocity distributions for both light (n=43) and heavy (n=69)
particles can be modeled with a Gaussian distribution (Shapiro-
Wilk test for normality; p-value.0.6) (Fig. 8). Heavy particles
moved with an average velocity of 2.1760.04 mm/s while light
particles traveled at 2.1360.07 mm/s (Table 2). The differences
between the two velocities were not statistically significant (t test;
alpha=0.05). The average velocity of capsids moving in the
retrograde direction was 0.7060.04 mm/s (n=39) (Table 2).
Previous studies in chick dorsal root sensory neurons have
reported a similar anterograde capsid velocity and a retrograde
velocity twice that obtained in this study [3]. This apparent
discrepancy may be due to differences in the type of neuron used.
Discussion
The microfluidic chamber provides a facile platform for
studying neuron-to-cell transmission of infection and viral
transport in vitro. The chamber is fabricated using soft lithography,
resulting in reproducible and high-throughput experiments. It uses
hydrostatic pressure to fluidically isolate virus to one compartment
of the chamber. This feature eliminates the need to apply a silicon
grease layer. The chamber is compatible with classical virology
methods such as titering and immunofluorescence assays for
assessing neuron-to-cell spread. Furthermore, it is suited for high-
resolution live imaging of viral axonal transport.
Figure 5. Live imaging of capsid and VP22 transport dynamics
inside the microfluidic chamber. Cell bodies in the somal
compartment were infected with PRV 181, a recombinant expressing
an mRFP-VP26 (capsid) fusion and a GFP-VP22 (outer tegument) fusion.
Time-lapse images were taken of axons within the microgrooves at 11–
14 h postinfection using the Leica SP5 confocal microscope. A typical
region of interest is outlined in the brightfield image. Zoom images
show an mRFP punctum moving in the retrograde direction (red arrow)
and an mRFP punctum co-transporting with GFP-VP22 punctum in
anterograde motion (yellow arrow). For a complete time-lapse
recording, see Movie S1 in the supporting information. Bar: 50 mm.
doi:10.1371/journal.pone.0002382.g005
Figure 6. Imaging transport of light and heavy particles inside
the microfluidic chamber. Cell bodies in the somal compartment
were infected with PRV 181, a recombinant expressing an mRFP-VP26
(capsid) fusion and a GFP-VP22 (outer tegument) fusion. Time-lapse
images were taken of axons within the microgrooves at 11–14 h
postinfection using the Leica SP5 confocal microscope. Green puncta of
light particles containing GFP-VP22 without mRFP-VP26 (green and
blue arrows) and yellow punta of heavy particles containing both GFP-
VP22 and mRFP-VP26 (yellow and orange arrows) were seen moving in
the anterograde direction. Both light and heavy particles displayed
heterogeneity in GFP fluorescence. For a complete time-lapse
recording, see Movie S2 in the supporting information. Bar: 2 mm.
doi:10.1371/journal.pone.0002382.g006
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analysis of neuron-to-cell spread of alpha-herpesvirus infection
from SCG neurons to epithelial cells. This spread is axon-
mediated, and requires the presence of the gE, gI, and Us9
proteins, but not gD. In addition, gB-mediated fusion is required.
By these criteria, our system faithfully recapitulates in vivo
anterograde spread of infection from presynaptic neurons to
postsynaptic cells in close proximity. Furthermore, the chamber
can be used to study retrograde spread of infection to cell bodies.
The microfluidic chamber offers technical advantages over
previous Campenot chambers that have been developed to study
viral spread from neurons to cells [9–12,14,15]. First, axons grow
through embedded microgrooves in the microfluidic chamber and
hence are not disturbed throughout the experiment. Previous
chambers require silicone grease or agarose to be applied on top of
axons as a viral diffusion barrier. An imperfect grease seal often led
to leakiness and disruption of neurites. Second, the microgrooves
allow for high efficiency of axonal isolation in the axonal
compartment. Other chamber systems utilize axon guidance
grooves etched on the culturing surface to encourage axon growth
under the chamber, which may result in low efficiency of axon
penetration and incompatibility with live-cell imaging. Third, the
microfluidic chamber can be easily adapted to isolate proximal
and distal segments of the axon by varying the length of the
microgrooves. Fourth, the directionality of the microgrooves
defines retrograde and anterograde transport during time-lapse
imaging. A large number of axons can be analyzed in a given
chamber, facilitating quantification of transport.
Using live-cell laser scanning microscopy, we imaged capsid and
tegument protein transport in axons within the microgrooves of
the chamber during viral egress. We isolate virus to the somal
compartment, hence separating the site of infection from the site of
imaging. This method removes potential ambiguities introduced
by uptake of input virions at axon termini and clarifies transport
direction.
We observed that a large proportion of GFP-VP22 puncta
traveled in the anterograde direction independent of capsid puncta
(54.6% of total). These structures are likely to be light particles and
have a velocity distribution similar to that of heavy particles. This
observation suggests that capsid structures do not influence the
kinetics of anterograde transport. Rather, both heavy and light
particles may be carried by host transport vesicles targeted to the
axon terminal. Alternatively, a virus protein may recruit kinesin
motors to transport viral particles in a capsid-independent
manner. The Gaussian velocity distribution indicates that a single
class of kinesin motor is likely responsible for anterograde
Figure 7. Transport direction of capsids and VP22 in axons
during viral egress. Cell bodies in the somal compartment were
infected with PRV 181, a recombinant expressing an mRFP-capsid fusion
and a GFP-VP22 fusion. Viral particles traveling in axons within the
microgrooves were tracked from 11–14 h postinfection. The fraction of
capsids transported with (black) or without (white) VP22 and the
fraction of VP22 moving in the absence of capsids (grey) are shown as
percentages of the total particles tracked.
doi:10.1371/journal.pone.0002382.g007
Figure 8. Distribution of transport velocities for heavy and light particles. Histogram of anterograde transport velocities of individual heavy
(n=69) (A) and light (n=43) (B) particles resulting from infections of cell bodies in the somal compartment with PRV 181. The best-fit Gaussian curve
for each sample is shown.
doi:10.1371/journal.pone.0002382.g008
Table 2. Transport velocities of capsids and VP22 during viral
egress.
Anterograde Retrograde
Capsid+VP22 VP22 alone Capsid alone
n 69 43 39
Velocity
1 (mm/s) 2.1760.04 2.1360.07 0.7060.04
1Average6standard error of the mean.
doi:10.1371/journal.pone.0002382.t002
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these light particles remains to be determined, but they likely
contain tegument and envelope proteins [55].
We have demonstrated that the microfluidic chamber provides
a unique tool to study the spread of alphaherpesviruses through
time-lapse imaging of axonal transport. There has been a
controversy regarding whether herpesvirus components enter the
axon as a complete virion, or as subassemblies, with membrane
proteins, tegument, and capsids moving separately into axons
[11,12,56–64]. Many of these studies employed imaging of fixed
and stained neurons and were thus unable to reflect transport
dynamics. In previous live-cell studies, the authors were unable to
completely rule out the possibility that the viral particles imaged
resulted from endocytosis of virions from the input inoculum
[59,64]. Using the microfluidic chamber, we can unambiguously
determine the nature of progeny virions targeted to axons and
begin to elucidate the effectors of viral transport.
Importantly, the chamber is adaptable for culturing other types
of neurons, including central nervous system neurons, and for
patterned cell culture [39]. Culturing of patterned cells inside the
microfluidic device allows for the creation of neuronal circuits,
potentially enabling us to study circuit-specific spread of alpha-
herpesviruses in vitro. The chamber is moreover amenable to
studying other neurotropic viruses and infectious agents.
Supporting Information
Movie S1 Time-lapse recording of capsid and VP22 transport
dynamics inside the microfluidic chamber. Cell bodies in the
somal compartment were infected with PRV 181, a recombinant
expressing an mRFP-VP26 (capsid) fusion and a GFP-VP22 (outer
tegument) fusion. Time-lapse images were taken of axons within
the microgrooves at 11–14 h postinfection using the Leica SP5
confocal microscope. Images were acquired at 4 frames/s.
Found at: doi:10.1371/journal.pone.0002382.s001 (5.16 MB AVI)
Movie S2 Time-lapse recording of the transport of light and
heavy particles inside the microfluidic chamber. Cell bodies in the
somal compartment were infected with PRV 181, a recombinant
expressing an mRFP-VP26 (capsid) fusion and a GFP-VP22 (outer
tegument) fusion. Time-lapse images were taken of axons within
the microgrooves at 11–14 h postinfection using the Leica SP5
confocal microscope. Images were acquired at 4 frames/s.
Found at: doi:10.1371/journal.pone.0002382.s002 (8.70 MB AVI)
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